Terms: = Sarcomas AND CTNNB1, P35222, 1499, ENSG00000168036, CTNNB
97 results:
1. The anoikis-related gene signature predicts survival and correlates with immune infiltration in osteosarcoma.
Li J; Wang H; Wu F; Yao J; Zhu H; Zhang M
Aging (Albany NY); 2024 Jan; 16(1):665-684. PubMed ID: 38217543
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic and predictive biomarkers in paediatric solid tumours.
Glembocki AI; Somers GR
Pathology; 2024 Mar; 56(2):283-296. PubMed ID: 38216399
[TBL] [Abstract] [Full Text] [Related]
3. Genomic and Molecular Characteristics of Ovarian Carcinosarcoma.
Ramphal K; Hadfield MJ; Bandera CM; Hart J; Dizon DS
Am J Clin Oncol; 2023 Dec; 46(12):572-576. PubMed ID: 37986208
[TBL] [Abstract] [Full Text] [Related]
4. Pseudoendocrine sarcoma: clinicopathologic, molecular, and epigenetic features of one case.
Vizcaino MA; Folpe AL; Huffman H; Panchal RR; Nielsen GP; Kipp BR; Turakulov R; Aldape K; Giannini C
Virchows Arch; 2023 Dec; 483(6):899-904. PubMed ID: 37953374
[TBL] [Abstract] [Full Text] [Related]
5. PDGFRβ Signaling Cooperates with β-Catenin to Modulate c-Abl and Biologic Behavior of Desmoid-Type Fibromatosis.
Hu J; Hameed MR; Agaram NP; Whiting KA; Qin LX; Villano AM; O'Connor RB; Rozenberg JM; Cohen S; Prendergast K; Kryeziu S; White RL; Posner MC; Socci ND; Gounder MM; Singer S; Crago AM
Clin Cancer Res; 2024 Jan; 30(2):450-461. PubMed ID: 37943631
[TBL] [Abstract] [Full Text] [Related]
6. Trauma and sporadic desmoid tumor development: An approach toward real incidence and aspects of causality.
Hohenberger P; Menge F; Hohenberger R; Kasper B; Marx A; Haller F; Baumgarten C; Wardelmann E; Jakob J
Cancer; 2024 Jan; 130(1):51-59. PubMed ID: 37751183
[TBL] [Abstract] [Full Text] [Related]
7. Endometrial/Endometrioid Stromal Tumors With Extensive Whorling and ctnnb1 Translocation : A Report of 3 Cases.
Boyraz B; da Cruz Paula A; Deveraux KA; Tran I; da Silva EM; Young RH; Snuderl M; Weigelt B; Oliva E
Am J Surg Pathol; 2023 Nov; 47(11):1285-1290. PubMed ID: 37584555
[TBL] [Abstract] [Full Text] [Related]
8. Uterine MEIS1::NCOA2 Fusion Sarcoma With Lung Metastasis: A Case Report and Review of the Literature.
Xing D; Meyer CF; Gross JM; Argani P; Hung CF; Wu TC; Vang R; Armstrong DK; Gaillard SL
Int J Gynecol Pathol; 2024 Jan; 43(1):47-55. PubMed ID: 37043646
[TBL] [Abstract] [Full Text] [Related]
9. Estrogen/Progesterone Receptor Loss, ctnnb1 and KRAS Mutations Are Associated With Local Recurrence or Distant Metastasis in Low-Grade Endometrial Endometrioid Carcinoma.
Chibbar R; Foerstner S; Suresh J; Chibbar R; Piche A; Kundapur D; Kanthan R; Kundapur V; Lee CH; Agrawal A; Lai R
Appl Immunohistochem Mol Morphol; 2023 Mar; 31(3):181-188. PubMed ID: 36695555
[TBL] [Abstract] [Full Text] [Related]
10. Case report: pseudoendocrine sarcoma, a clinicopathologic report of a newly described soft tissue neoplasm.
Bellan E; Zanco F; Baciorri F; Toffolatti L; Dei Tos AP; Sbaraglia M
Virchows Arch; 2023 Jun; 482(6):1057-1063. PubMed ID: 36564514
[TBL] [Abstract] [Full Text] [Related]
11. Targeted next-generation sequencing reveals activating ctnnb1 mutations in SMARCA4/BRG1-deficient sinonasal carcinomas: a report of two new cases and a brief review of the literature with an emphasis on histogenesis.
Zhao M; Ma T; He X; Ge M
Virchows Arch; 2023 Feb; 482(2):453-460. PubMed ID: 36396744
[TBL] [Abstract] [Full Text] [Related]
12. Comprehensive Molecular Profiling of Sinonasal Teratocarcinosarcoma Highlights Recurrent SMARCA4 Inactivation and ctnnb1 Mutations.
Rooper LM; Agaimy A; Gagan J; Simpson RHW; Thompson LDR; Trzcinska AM; Ud Din N; Bishop JA
Am J Surg Pathol; 2023 Feb; 47(2):224-233. PubMed ID: 36206446
[TBL] [Abstract] [Full Text] [Related]
13. Circ-ctnnb1 drives aerobic glycolysis and osteosarcoma progression via m6A modification through interacting with RBM15.
Yang F; Liu Y; Xiao J; Li B; Chen Y; Hu A; Zeng J; Liu Z; Liu H
Cell Prolif; 2023 Jan; 56(1):e13344. PubMed ID: 36181462
[TBL] [Abstract] [Full Text] [Related]
14. The Role of Pharmacotherapeutic Agents in Children with Desmoid Tumors.
Douglass DP; Navid F; Weiss AR
Paediatr Drugs; 2022 Sep; 24(5):433-445. PubMed ID: 35902507
[TBL] [Abstract] [Full Text] [Related]
15. miR-2682-3p antagonizes its host lncRNA-MIR137HG by interacting with the same target FUS to regulate the progression of gastric cancer.
Du Y; Chen Y; Wu T; Fan X; Lin W; Jiang Z
BMC Cancer; 2022 Jun; 22(1):689. PubMed ID: 35733138
[TBL] [Abstract] [Full Text] [Related]
16. Congenital Teratocarcinosarcoma With
Almarzooqi S; Reyes-Múgica M; Ali BR; Habbal A; Asha MJ; AlShamsi ET
Pediatr Dev Pathol; 2022; 25(5):562-567. PubMed ID: 35732187
[TBL] [Abstract] [Full Text] [Related]
17. Desmoid tumors located in the abdomen or associated with adenomatous polyposis: French intergroup clinical practice guidelines for diagnosis, treatment, and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR).
Benech N; Bonvalot S; Dufresne A; Gangi A; Le Péchoux C; Lopez-Trabada-Ataz D; Meurgey A; Nicolas N; Orbach D; Penel N; Salas S; Saurin JC; Walter T; Lecomte T; Bouché O; ; ; ; ; ; ; ; ; ;
Dig Liver Dis; 2022 Jun; 54(6):737-746. PubMed ID: 35508462
[TBL] [Abstract] [Full Text] [Related]
18. Spatial profiling reveals association between WNT pathway activation and T-cell exclusion in acquired resistance of synovial sarcoma to NY-ESO-1 transgenic T-cell therapy.
Campbell KM; Thaker M; Medina E; Kalbasi A; Singh A; Ribas A; Nowicki TS
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35264439
[TBL] [Abstract] [Full Text] [Related]
19. A Prospective Observational Study of Active Surveillance in Primary Desmoid Fibromatosis.
Colombo C; Fiore M; Grignani G; Tolomeo F; Merlini A; Palassini E; Collini P; Stacchiotti S; Casali PG; Perrone F; Mariani L; Gronchi A
Clin Cancer Res; 2022 Sep; 28(18):4027-4032. PubMed ID: 35247923
[TBL] [Abstract] [Full Text] [Related]
20. In desmoid-type fibromatosis cells sorafenib induces ferroptosis and apoptosis, which are enhanced by autophagy inhibition.
Schut AW; Vriends ALM; Sacchetti A; Timbergen MJM; Alman BA; Al-Jazrawe M; Grünhagen DJ; Verhoef C; Sleijfer S; Wiemer EAC
Eur J Surg Oncol; 2022 Jul; 48(7):1527-1535. PubMed ID: 35221159
[TBL] [Abstract] [Full Text] [Related]
[Next]
